WINSTON-SALEM, N.C., Aug. 29 (UPI) -- A class of oral drugs used to treat type 2 diabetes may increase the risk of heart failure, two Wake Forest University School of Medicine faculty members said.
TORONTO, Dec. 12 (UPI) -- Older patients treated for diabetes with thiazolidinediones had an increased risk of heart attack, congestive heart failure and death, a U.S. study found.
WASHINGTON, Nov. 20 (UPI) -- A U.S. Senate panel is examining claims a top official at the Gates Foundation tried to cover up a diabetes drug's potential side effects in his previous job.
WASHINGTON, Nov. 14 (UPI) -- The diabetes drug Avandia will add information to its warning that the popular drug may increase the risk of heart attack, U.S. regulators said.
WINSTON-SALEM, N.C., Sept. 12 (UPI) -- U.S. scientists have discovered long-term use of the popular diabetes drug Avandia can increase a person's risk of heart attack.
WASHINGTON, Aug. 15 (UPI) -- The U.S. Food and Drug Administration said manufacturers of certain type 2 diabetes drugs have agreed to add a stronger heart failure warning on drug labels.
WASHINGTON, July 30 (UPI) -- A drug-safety advisory committee said Monday GlaxoSmithKline PLC's diabetes drug Avandia should stay on the U.S. market, despite its heart-attack risks.
WASHINGTON, July 27 (UPI) -- A U.S. drug review panel said patients should be warned that taking Avandia for diabetes increases their risk of heart attacks.
CHICAGO, July 12 (UPI) -- A common malaria treatment could help protect rheumatoid arthritis patients from diabetes.
CHICAGO, June 25 (UPI) -- Cardiologist Steven Nissen -- who made recent headlines with an analysis linking diabetes drug Avandia to a heart risk -- defended his work Monday.
WASHINGTON, June 7 (UPI) -- The U.S. Food and Drug Administration is requesting safety warnings for diabetes drugs Avandia and Actos after they came under congressional scrutiny.
WASHINGTON, June 6 (UPI) -- The maker of Avandia said ahead of a congressional hearing about the diabetes drug's safety that it doesn't raise the risk of heart disease.
WASHINGTON, June 6 (UPI) -- A potential heart attack risk linked to Avandia is "particularly concerning" since the drug is used by diabetics, a U.S. doctor told lawmakers Wednesday.
ROCKVILLE, Md., May 21 (UPI) -- The blockbuster diabetes drug, GlaxoSmithKline's Avandia may carry a higher risk of heart attack, the U.S. Food and Drug Administration says.
WASHINGTON, May 21 (UPI) -- The U.S. Food and Drug Administration issued a safety alert concerning the drug Avandia (rosiglitazone), which is used to treat type 2 diabetes.
